Newsroom

Sorted by: Latest

-

AM Best Revises Issuer Credit Rating Outlook to Negative for Investors Heritage Life Insurance Company

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has revised the outlook to negative from stable for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of B++ (Good) and the Long-Term ICR of “bbb+” (Good) of Investors Heritage Life Insurance Company (IHLIC) (Frankfort, KY). The outlook of the FSR is stable. The ratings reflect IHLIC’s balance sheet strength, which AM Best assesses as adequate, as well as its adequate operating performance, neutral busines...
-

UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Universal Health Services’ Directors and Officers for Breach of Fiduciary Duties – UHS

NEW YORK--(BUSINESS WIRE)--UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Universal Health Services’ Directors and Officers...
-

BRIGHT HORIZONS FAMILY SOLUTIONS INC. INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Bright Horizon Family Solutions Inc.’s Directors and Officers for Breach of Fiduciary Duties – BFAM

NEW YORK--(BUSINESS WIRE)--BRIGHT HORIZONS FAMILY SOLUTIONS INC. INVESTOR ALERT: Haeggquist & Eck, LLP Investigates Bright Horizon Family Solutions Inc.’s Directors and Officers...
-

DWS Municipal Income Trust Declares Monthly Distribution

NEW YORK--(BUSINESS WIRE)--DWS Municipal Income Trust (KTF) (the “Fund”) announced today its regular August monthly distribution. Details are as follows: Declaration – 08/07/2026 Ex-Date – 08/19/2026 Record – 08/19/2026 Payable – 08/31/2026   Fund   Ticker   Distribution Per Share   Prior Distribution Per Share   DWS Municipal Income Trust   KTF   $0.0610   $0.0610 The Fund intends to distribute all or substantially all of its net investment income each year through its regular monthly distribu...
-

AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Aug. 10, 2026...
-

Mueller Industries, Inc. Announces Retirement of Gary S. Gladstein from the Board of Directors Effective December 31, 2026

COLLIERVILLE, Tenn.--(BUSINESS WIRE)--Mueller Industries, Inc. (NYSE: MLI) announced today that effective December 31, 2026, Gary S. Gladstein, who has served on the Board a combined 30 years, including three years as Chairman and three years as Lead Independent Director, will retire from Board service. On the transition, Greg Christopher, Chairman and CEO, stated, “We are grateful for Gary’s commitment to our Company and thank him for his three decades of service. Gary has played an instrument...
-

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
-

Penske Automotive Group, Inc. (PAG) Investigation: Halper Sadeh LLC Investigates Whether the Proposed Buyout of Penske Automotive Group, Inc. for $210.00 Per Share Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the potential sale of Penske Automotive Group, Inc. (NYSE: PAG) to Penske Corporation and Mitsui & Co., Ltd. On July 22, 2026, Penske Automotive reported that it had received an unsolicited, preliminary, and non-binding proposal from Penske Corporation and Mitsui & Co., Ltd.—which together with their affiliates own approximately 72.6% of the company’s stock—to acquire the remaining shares of Pensk...
-

Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of patients with rare, severe, and debilitating neuromuscular diseases by applying its world-leading platform in myostatin biology, today announced that the FDA review of the apitegromab Biologics License Application (BLA) for the treatment of children and adults with spinal muscular atrophy (SMA) is progressing with the Company’s second fill-finish facility. The B...
-

The Twelfth Annual iHeartMedia New York’s Z100 Summer Bash Presented by Wells Fargo Celebrated Summer with a Free Concert at Hudson Yards on August 6

NEW YORK--(BUSINESS WIRE)--iHeartMedia New York’s Z100, New York’s Number 1 Hit Music Station, hosted its free end-of-summer concert event, Z100’s Summer Bash Presented by Wells Fargo, on Thursday, August 6, at 6 p.m. ET at the Public Square & Gardens at Hudson Yards in New York City. The event featured performances from Charlie Puth, Bella Kay, Yeonjun and JYT. Z100’s Summer Bash Presented by Wells Fargo was hosted by iHeartMedia New York’s Z100 on-air personalities. Sponsor activations cr...